Patents by Inventor Carl G. Gahmberg

Carl G. Gahmberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide ligands of leukocyte integrins
    Patent number: 7205383
    Abstract: The present invention relates to novel peptides which are useful as antagonists of the ?2 integrins, to pharmaceutical compositions comprising these peptides, to the use of the novel peptides for the manufacture of pharmaceutical compositions for the treatment of inflammatory diseases and human leukemias and for inhibiting leukocyte cell adhesion and migration in general, to a method for therapeutic or prophylactic treatment of inflammatory diseases and human leukemias and to the use of the novel peptides as ?2 integrin antagonists for biochemical isolation and purification procedures in vitro.
    Type: Grant
    Filed: March 11, 2002
    Date of Patent: April 17, 2007
    Assignee: Karyon-CTT Ltd.
    Inventors: Erkki Koivunen, Carl G. Gahmberg
  • Novel peptide ligands of leukocyte integrins
    Publication number: 20040259798
    Abstract: The present invention relates to novel peptides which are useful as antagonists of the &bgr;2 integrins, to pharmaceutical compositions comprising these peptides, to the use of the novel peptides for the manufacture of pharmaceutical compositions for the treatment of inflammatory diseases and human leukemias and for inhibiting leukocyte cell adhesion and migration in general, to a method for therapeutic or prophylactic treatment of inflammatory diseases and human leukemias and to the use of the novel peptides as &bgr;2 integrin antagonists for biochemical isolation and purification procedures in vitro.
    Type: Application
    Filed: August 27, 2003
    Publication date: December 23, 2004
    Inventors: Erkki Koivunen, Carl G. Gahmberg